RecruitingNot ApplicableNCT05378581

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children

Evaluation of the Use of a Virtual Reality Mask During Blood Tests and Prick Tests Performed in Allergic Children Aged 7 to 13 Years: a Multicenter, Randomized Trial


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

300 participants

Start Date

Sep 23, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Main objective : Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years. Hypothesis : Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxiety and pain


Eligibility

Min Age: 7 YearsMax Age: 13 Years

Inclusion Criteria4

  • Children from 7 to 13 years old requiring blood test and prick tests in pediatric consultation at the Clermont-Ferrand University Hospital and in the pediatric's day hospital at the Saint-Etienne University Hospital
  • Subjects and their parents who were informed about the study and gave informed consent
  • Enrollment in the Social Security system
  • Children and parents able to use the self-report scales proposed in the study

Exclusion Criteria7

  • Children from 7 to 13 :
  • presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post-traumatic stress disorder)
  • Having a modification of pain's integration (spina bifida for example)
  • Having received an analgesic before the care
  • Requiring contact isolation
  • With a history of seizures or motion sickness
  • Refusal of the parents and/or the child

Interventions

DEVICEVirtual reality mask

virtual reality mask Deepsen® with age-appropriate software Birdy®

OTHERcontrol arm

usual process


Locations(2)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

CHU de Saint Etienne

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05378581


Related Trials